⌘K

Login Start Free

Home/Filings/4/0001615219-20-000024

4//SEC Filing

Lammers Paul 4

Accession 0001615219-20-000024

CIK 0001615219other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 6:01 PM ET

Size

5.3 KB

Accession

0001615219-20-000024

Insider Transaction Report

Form 4

Period: 2020-03-23

Salarius Pharmaceuticals, Inc.SLRX

Director

Transactions

Award
Stock Option (right to buy)
2020-03-23+6,000→ 6,000 total
Exercise: $0.61Exp: 2030-03-22→ Common Stock (6,000 underlying)

Footnotes (1)

[F1]Options granted are fully vested on March 23, 2021.

Documents

1 file

4
wf-form4_158517370098647.xmlPrimary
FORM 4

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1

filerCIK 0001457289

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 6:01 PM ET
Size: 5.3 KB

View on SEC.gov